Trial intelligence / Profile preview

NTx 265 in Traumatic Brain Injury

NCT01239706Phase 2Unknown

Sponsor
University of Calgary
Start
Nov 2010
Primary completion
Jun 2012
Countries
1
01

Overview

A Phase 2 trial of NTx-265 in traumatic brain injury (TBI), sponsored by University of Calgary. Status: unknown.

02

Drugs

NTx-265
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT01239706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01239706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call